Roche Holding AG
Research Roche Holding AG (RHO6) on Bullrun: P/E 25.4, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRHO6
- ExchangeSTU
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- P/E25.4
- Dividend yield2.6%
- Financial periodFY2025
- RevenueCHF 63.36B
- Revenue growth1.5%
- Net incomeCHF 12.88B
- Free cash flowCHF 13.07B
- Gross margin73.7%
Valuation Snapshot
P/E is 25.4; dividend yield is 2.6%.
Peer valuation comparison
Latest P/E is 25.44x versus a Healthcare sector median of 21.8x (16.7% above).
Latest dividend yield is 2.64% versus a Healthcare sector median of 2.41% (9.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 63.36B | CHF 12.88B | CHF 13.07B | 73.7% | 16.04 | CHF 5.58B | CHF 33.19B | CHF 33.80B |
| FY2024 | CHF 62.40B | CHF 8.28B | CHF 15.09B | 73.9% | 10.31 | CHF 6.98B | CHF 36.35B | CHF 31.77B |
| FY2023 | CHF 60.44B | CHF 11.50B | CHF 11.45B | 72.9% | 14.31 | CHF 5.38B | CHF 30.78B | CHF 29.32B |
| FY2022 | CHF 65.81B | CHF 12.42B | CHF 13.25B | 70.0% | 15.37 | CHF 4.99B | CHF 26.54B | CHF 27.99B |
| FY2021 | n/a | n/a | n/a | n/a | 2.03 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-29 | n/a | 25.4 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: yield 2.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.2 CHF |
| FY2024 | 1.17 CHF |
| FY2023 | 1.11 CHF |
| FY2022 | 1.07 CHF |
| FY2021 | 1.06 CHF |
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Roche Holding AG's P/E ratio?
Roche Holding AG's price-to-earnings (P/E) ratio is 25.4.
Does Roche Holding AG pay a dividend?
Roche Holding AG has a dividend yield of 2.6%.
What does Roche Holding AG do?
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.